MDS shows a higher expression of hTERT and alternative splice variants in unactivated T-cells

Autor: Houfang Sun, Lili Yang, Xiubao Ren, Wen Dong, Pearlie K. Epling-Burnette, Lei Wu
Rok vydání: 2016
Předmět:
Zdroj: Oncotarget
ISSN: 1949-2553
Popis: // Wen Dong 1, * , Lei Wu 2, 3, 4, * , Houfang Sun 2, 3, 4 , Xiubao Ren 2, 3, 4 , Pearlie K. Epling-Burnette 5 , Lili Yang 2, 3, 4 1 Department of Orthopaedic Surgery, Tianjin Hongqiao Hospital, Tianjin, P.R. China 2 Department of Immunology, Tianjin Cancer Institute and Hospital, Tianjin Medical University, P.R. China 3 National Clinical Research Center of Cancer, P.R. China 4 Key Laboratory of Cancer Immunology and Biotherapy, Tianjin, P.R. China 5 Immunology Program at the H. Lee Moffitt Cancer Center, Tampa, FL, USA * These authors have contributed equally to this work Correspondence to: Lili Yang, email: yanglili@tjmuch.com Pearlie K. Epling-Burnette, email: Pearlie.Burnette@moffitt.org Keywords: MDS, T-cells, telomerase, hTERT, hTERT alternative splice variants Received: July 27, 2016 Accepted: September 10, 2016 Published: September 19, 2016 ABSTRACT Telomere instability and telomerase reactivation are believed to play an important role in the development of myelodysplastic syndromes (MDS). Abnormal enzymatic activity of human telomerase reverse transcriptase (hTERT), and its alternative splice variants have been reported to account for deregulated telomerase function in many cancers. In this study, we aim to compare the differences in expression of hTERT and hTERT splice variants, as well as telomere length and telomerase activity in unstimulated T-cells between MDS subgroups and healthy controls. Telomere length in MDS cases was significantly shorter than controls (n = 20, p
Databáze: OpenAIRE